Sosei, AbbVie collaborate on new medicine for autoimmune diseases
The collaboration will leverage advanced StaR technology and SBDD platform to discover the advanced medicines that modulate GPCRs
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Jun 20
The collaboration will leverage advanced StaR technology and SBDD platform to discover the advanced medicines that modulate GPCRs
24 Jun 20
Oncomine Dx Target Test identifies NSCLC in patients with human epidermal growth factor receptor 2 (HER2) mutations who…
23 Jun 20
Betta will receive exclusive rights for the development and commercialisation of balstilimab and zalifrelimab in greater China
15 Jun 20
IVA is aimed at accelerating the supply of the vaccine and to ensure its availability to other European…
09 Jun 20
The two companies have already started enrolling patients for the initial multicentre, open-label study to evaluate the combination…
05 Jun 20
Through the agreements, AstraZeneca aims to provide global access to the vaccine, including low and middle-income countries
04 Jun 20
NVX-CoV2373 is a stable, prefusion protein designed by Novavax, leveraging its original nanoparticle technology, to work against SARS-CoV-2…
28 May 20
Thermo Fisher will leverage its drug product development, biologics manufacturing, sterile fill-finish, packaging and clinical trials logistics to…
21 May 20
CanSinoBIO will hold rights to commercialise the vaccine product in Asia, except in Japan, while PNI will retain…
14 May 20
Remdesivir is an investigational medicine that has been granted the US Food and Drug Administration (FDA) EUA to…